• 347-746-6001
  • contact@beynensonlaw.com
Beynenson Law
Beynenson Law
  • Services
    • Search Case Law & Regulations
    • New Decisions
    • Decisions by Court
    • Legal Questions
    • No-Fault Regulations
    • Claim Process & Deadlines
    • Ask No-Fault AI
    • Arbitrator Scorecard
    • Award Volume
    • Arbitrator / Carrier Data
    • Provider / Carrier Data
    • Provider / Attorney Data
    • Arbitration Pro Extension
  • About Us
  • Contact
  • East Hampton, New York

  • 347-746-6001
  • contact@beynensonlaw.com
  • Services
    • Search Case Law & Regulations
    • New Decisions
    • Decisions by Court
    • Legal Questions
    • No-Fault Regulations
    • Claim Process & Deadlines
    • Ask No-Fault AI
    • Arbitrator Scorecard
    • Award Volume
    • Arbitrator / Carrier Data
    • Provider / Carrier Data
    • Provider / Attorney Data
    • Arbitration Pro Extension
  • About Us
  • Contact
July 16, 2010

Kipor Medicine, P.C. v GEICO (2010 NY Slip Op 51247(U))

https://www.beynensonlaw.com/case-law/kipor-medicine-p-c-v-geico-2010-ny-slip-op-51247u/

Court
Appellate Term, Second Department
Decided
July 16, 2010
Citation
2010 NY Slip Op 51247(U) · 28 Misc 3d 129(A)
Posture
Other motion
Outcome
Provider prevailed
Later treatment
Followed in 3 later decisions (see Cited by)
Issues
Discovery and procedure Fraudulent incorporation (Mallela)
Legal questions
Mallela defense: preclusion and discovery · Fraudulent incorporation (Mallela) (see the maps)
Cite as
Kipor Medicine, P.C. v GEICO, 28 Misc 3d 129(A), 2010 NY Slip Op 51247(U) (App Term, 2d Dept, 2d, 11th & 13th Jud Dists 2010)

Posture, outcome, issues and treatment by other decisions are Beynenson Law’s classification. Treatment labels are assigned by a language model reading the citing decision; negative and appeal-history labels are checked by a second reader.

Summary

Editorial summary by Beynenson Law, not part of the court’s decision.

The insurer failed to support consolidation, amendment of its answer, and further discovery after the notice of trial. The Appellate Term, Second Department, reversed and denied the insurer's motion. Under CPLR 602 (a), the insurer showed no common questions among the actions; under CPLR 3025 (b), it offered no evidence of merit for its proposed defenses. The provider could wind up its affairs and recover for services predating its sole shareholder's license surrender, and the insurer did not demonstrate fraudulent incorporation under Mallela. Further discovery lacked an affidavit showing unusual or unanticipated post-notice conditions under 22 NYCRR 208.17 (d). A separate concurrence agreed with the result based on the insurer's delay but disagreed with the majority's reasoning.

Reported in New York Official Reports at Kipor Medicine, P.C. v GEICO (2010 NY Slip Op 51247(U))

[*1]
Kipor Medicine, P.C. v GEICO
2010 NY Slip Op 51247(U) [28 Misc 3d 129(A)]
Decided on July 16, 2010
Appellate Term, Second Department
Published by New York State Law Reporting Bureau pursuant to Judiciary Law § 431.
This opinion is uncorrected and will not be published in the printed Official Reports.


Decided on July 16, 2010
SUPREME COURT OF THE STATE OF NEW YORK

APPELLATE TERM: 2nd, 11th and 13th JUDICIAL DISTRICTS

PRESENT: : PESCE, P.J., WESTON and GOLIA, JJ
2009-763 K C. NO. 2009-763 K C

Kipor Medicine, P.C. a/a/o CECILIA LEWIS, MANUEL LINARES, LENA LINDSAY and ROBERT MALAYEV, Appellant,

against

GEICO, Respondent.


Appeal from an order of the Civil Court of the City of New York, Kings County (Dolores L. Waltrous, J.), dated May 29, 2008. The order granted defendant’s motion to consolidate this action with 13 other actions, to amend the answer to include two additional affirmative defenses, and to compel plaintiff to respond to discovery demands and produce its sole shareholder for an examination before trial.


ORDERED that the order is reversed without costs and defendant’s motion to consolidate this action with 13 other actions, to amend the answer to include two additional affirmative defenses, and to compel plaintiff to respond to discovery demands and produce its sole shareholder for an examination before trial is denied.

In this action by a provider to recover assigned first-party no-fault benefits, defendant moved to consolidate this action with 13 other pending actions commenced
by the same provider against defendant. Defendant also sought leave to amend the answer to assert two additional affirmative defenses, and to compel plaintiff to respond to specified discovery demands and produce its sole shareholder for an examination before trial. The Civil Court granted defendant’s motion, and plaintiff appeals.

The branch of defendant’s motion seeking consolidation should have been denied since defendant failed to demonstrate that the actions it sought to consolidate had common questions of law or fact (see CPLR 602 [a]; S & B Neurocare, P.C. v GEICO Ins. Co., 20 Misc 3d 132[A], 2008 NY Slip Op 51450[U] [App Term, 2d & 11th Jud Dists 2008]). In addition, the branch of [*2]defendant’s motion seeking leave to amend the answer should have been denied since defendant’s papers presented no evidence that the proposed amendment might have merit (see CPLR 3025 [b]; Ingrami v Rovner, 45 AD3d 806, 808 [2007]). Defendant sought to amend its answer to assert that plaintiff’s certificate of incorporation had been revoked following the surrender, in April 2006, of the medical license of plaintiff’s sole shareholder. Plaintiff, however, is entitled to wind up its affairs and seek to recover no-fault benefits for the services it rendered to its assignors prior to April 2006 (see e.g. A.B. Med. Servs., PLLC v Travelers Indem. Co., 26 Misc 3d 69 [App Term, 9th & 10th Jud Dists 2009]). Defendant has not demonstrated that the facts herein are akin to a fraudulent incorporation (see State Farm Mut. Auto. Ins. Co. v Mallela, 4 NY3d 313 [2005]).

Moreover, since defendant failed to submit an affidavit specifying that any unusual or unanticipated conditions had developed after the notice of trial had been filed which made it necessary for defendant to engage in further pretrial proceedings (see Uniform Rules for New York City Civ Ct [22 NYCRR] § 208.17 [d]; S & B Neurocare, P.C. v GEICO Ins. Co., 20 Misc 3d 132[A], 2008 NY Slip Op 51450[U]), the branch of defendant’s motion seeking to compel plaintiff to respond to discovery demands and produce its sole shareholder for an examination before trial should also have been denied.

Accordingly, the order is reversed and defendant’s motion is denied.

Pesce, P.J., and Weston, J., concur.

Golia, J., concurs in a separate memorandum.
SUPREME COURT OF THE STATE OF NEW YORK
APPELLATE TERM : 2nd, 11th and 13th JUDICIAL DISTRICTS
PRESENT : PESCE, P.J., WESTON and GOLIA, JJ.
KIPOR MEDICINE, P.C. a/a/o CECILIA LEWIS,
MANUEL LINARES, LENA LINDSAY and
ROBERT MALAYEV,

Appellant,

-against-
GEICO,

Respondent. [*3]

Golia, J., concurs in the result in the following memorandum:

While I concur with the ultimate decision, I disagree with the reasoning set forth by the majority. The sole shareholder in the plaintiff corporation was Vlad Meisher, M.D. Dr. Meisher pleaded guilty to insurance fraud on April 18, 2006 regarding claims filed with GEICO over the time period of January 1, 2000 through July 1, 2004. He lost his license to practice medicine and thereafter had his certification of incorporation revoked on December 11, 2006.

This action was commenced in Civil Court in or about March 2004, and, not being deterred by his guilty plea, plaintiff filed a notice of trial in October 2006. Nothing of any import occurred in this matter for the next 17 months until March 2008, when defendant filed the subject motion on the eve of trial. The motion sought to consolidate this matter with 13 other actions pending between the same parties. In addition, defendant sought leave to amend the answer to include two additional affirmative defenses concerning the alleged improprieties and the question of fraud as well as seeking additional discovery.

Unlike the majority, I do not find that defendant failed to demonstrate that the actions it sought to consolidate had common questions of law or fact,” or that defendant’s papers presented no evidence that the proposed amendment might have merit,” or that additional discovery should also have been denied.” Notwithstanding the foregoing, I agree with the majority in the ultimate result in that defendant waited nearly two years from the time it knew that Dr. Meisher had committed insurance fraud and was losing his medical license. Indeed, it was this very defendant, GEICO, that was the named victim” in the case to which Dr. Meisher entered his guilty plea. I can find no valid reason for this particular defendant to have ignored these concerns for such an extended period of time. Certainly, if defendant had submitted the same motion within a reasonable time, I would have voted to affirm the order of the Civil Court.

Unlike the majority, however, I view defendant’s three requests (to consolidate, amend the answer, and demand discovery) as a unitary application that is predicated upon plaintiff’s sole shareholder having acknowledged that he was guilty of insurance fraud. Under those circumstances, the ground for consolidation is a common question of law and fact surrounding the extent of the fraud admittedly perpetrated by plaintiff. Similarly, it would further establish the need for defendant to amend the answer and to obtain additional discovery in order to discern and prove the extent of the fraud committed. Notwithstanding the above views, defendant’s failure to raise these issues in a timely manner compels me to agree with the ultimate finding of the majority.
Decision Date: July 16, 2010

Legal questions (2)

Questions of no-fault law this decision rules on, from our Legal Questions pages. Bars count the decisions on the question by year and court, coloured by category; circles are this decision and the decisions on the question it cites or that cite it. Point at a bar or circle for details. The categories and summaries are Beynenson Law’s classification, made by a language model and checked by a second reading.

Mallela defense: preclusion and discovery

Open the full map

May the insurer raise and investigate a Mallela (fraudulent incorporation) defense, or is it precluded, waived or denied discovery?

This decision: Insurer may not pursue or investigate the Mallela defense here

Denied leave to amend the answer to add an ineligibility defense based on revocation of incorporation after the owner surrendered his license, because nothing showed merit or facts akin to fraudulent incorporation; the owner's deposition was also denied.

  • Court of AppealsCt App 1
  • Appellate DivisionApp Div 7
  • Appellate TermApp Term 72
  • Trial courtsTrial 56
2005, Court of Appeals: 1 decision (1 Defense may be pursued)2021, Appellate Division: 1 decision (1 Defense may be pursued)2019, Appellate Division: 2 decisions (1 Defense may be pursued, 1 Defense barred)2017, Appellate Division: 1 decision (1 Defense may be pursued)2016, Appellate Division: 1 decision (1 Defense may be pursued)2011, Appellate Division: 1 decision (1 Defense may be pursued)2008, Appellate Division: 1 decision (1 Defense may be pursued)2019, Appellate Term: 1 decision (1 Defense may be pursued)2018, Appellate Term: 2 decisions (2 Defense may be pursued)2017, Appellate Term: 2 decisions (2 Defense may be pursued)2014, Appellate Term: 2 decisions (2 Defense may be pursued)2013, Appellate Term: 5 decisions (5 Defense may be pursued)2012, Appellate Term: 8 decisions (8 Defense may be pursued)2011, Appellate Term: 8 decisions (7 Defense may be pursued, 1 Defense barred)2010, Appellate Term: 9 decisions (7 Defense may be pursued, 2 Defense barred)2009, Appellate Term: 7 decisions (7 Defense may be pursued)2008, Appellate Term: 8 decisions (7 Defense may be pursued, 1 Defense barred)2007, Appellate Term: 7 decisions (7 Defense may be pursued)2006, Appellate Term: 6 decisions (6 Defense may be pursued)2025, Appellate Term: 7 decisions (7 Defense may be pursued)2023, Trial courts: 2 decisions (2 Defense may be pursued)2021, Trial courts: 4 decisions (3 Defense may be pursued, 1 Defense barred)2019, Trial courts: 1 decision (1 Defense may be pursued)2017, Trial courts: 4 decisions (2 Defense may be pursued, 2 Defense barred)2015, Trial courts: 3 decisions (3 Defense may be pursued)2013, Trial courts: 2 decisions (1 Defense may be pursued, 1 Defense barred)2012, Trial courts: 6 decisions (1 Defense may be pursued, 5 Defense barred)2011, Trial courts: 1 decision (1 Defense barred)2010, Trial courts: 3 decisions (3 Defense barred)2009, Trial courts: 4 decisions (3 Defense may be pursued, 1 Defense barred)2008, Trial courts: 6 decisions (5 Defense may be pursued, 1 Defense barred)2007, Trial courts: 2 decisions (2 Defense may be pursued)2006, Trial courts: 5 decisions (5 Defense may be pursued)2005, Trial courts: 9 decisions (5 Defense may be pursued, 4 Defense barred)2025, Trial courts: 2 decisions (2 Defense may be pursued)2026, Trial courts: 2 decisions (2 Defense may be pursued)This decision
20052010201520202025
Defense may be pursuedDefense barredThis decisionCites it or cited by itCited or followed

Of the 136 decisions on this question in the Second Department courts and the Court of Appeals, 24 (this one included) are in the same category.

Fraudulent incorporation (Mallela)

Open the full map

On the merits, when may a no-fault insurer withhold payment because unlicensed persons own or control the provider (Mallela)?

This decision: Alleged conduct legally cannot support the ineligibility defense (rules on the question, but another ground decided the case)

Denied leave to amend the answer because revocation of the provider's certificate of incorporation after its sole shareholder surrendered his license did not bar recovery for earlier services and was not akin to fraudulent incorporation.

  • Court of AppealsCt App 3
  • Appellate DivisionApp Div 8
  • Appellate TermApp Term 26
  • Trial courtsTrial 24
2019, Court of Appeals: 1 decision (1 Defense established)2005, Court of Appeals: 1 decision (1 Defense established)2025, Court of Appeals: 1 decision (1 Not a Mallela ground)2019, Appellate Division: 4 decisions (2 Defense established, 2 Defense not established)2017, Appellate Division: 2 decisions (1 Defense established, 1 Defense not established)2016, Appellate Division: 1 decision (1 Triable issue)2008, Appellate Division: 1 decision (1 Triable issue)2020, Appellate Term: 1 decision (1 Not a Mallela ground)2019, Appellate Term: 1 decision (1 Defense established)2013, Appellate Term: 1 decision (1 Defense established)2012, Appellate Term: 1 decision (1 Not a Mallela ground)2010, Appellate Term: 6 decisions (2 Defense established, 1 Triable issue, 2 Defense not established, 1 Not a Mallela ground)2009, Appellate Term: 4 decisions (2 Defense established, 1 Triable issue, 1 Not a Mallela ground)2008, Appellate Term: 4 decisions (1 Defense established, 1 Triable issue, 2 Defense not established)2007, Appellate Term: 5 decisions (1 Defense established, 4 Triable issue)2006, Appellate Term: 2 decisions (1 Triable issue, 1 Defense not established)2015, Appellate Term: 1 decision (1 Defense not established)2019, Trial courts: 1 decision (1 Triable issue)2017, Trial courts: 2 decisions (1 Defense not established, 1 Not a Mallela ground)2015, Trial courts: 2 decisions (1 Defense established, 1 Not a Mallela ground)2013, Trial courts: 1 decision (1 Defense not established)2010, Trial courts: 1 decision (1 Not a Mallela ground)2009, Trial courts: 3 decisions (1 Defense established, 2 Triable issue)2008, Trial courts: 4 decisions (1 Defense established, 2 Triable issue, 1 Defense not established)2007, Trial courts: 2 decisions (1 Defense established, 1 Triable issue)2006, Trial courts: 3 decisions (3 Triable issue)2005, Trial courts: 4 decisions (3 Defense established, 1 Defense not established)2004, Trial courts: 1 decision (1 Not a Mallela ground)This decision
20052010201520202025
Defense establishedTriable issueDefense not establishedNot a Mallela groundThis decisionCites it or cited by itCited or followed

Of the 61 decisions on this question in the Second Department courts and the Court of Appeals, 9 (this one included) are in the same category.

Cited in this decision

A label shows how this decision treated the case it cites.

  • S & B Neurocare, P.C. v GEICO Ins. Co. (2008 NY Slip Op 51450(U)) FollowedThe insurer failed to justify consolidation, establish provider ineligibility as a matter of law, or support discovery after the notice of trial.
  • A.B. Med. Servs., PLLC v Travelers Indem. Co. (2009 NY Slip Op 29510)A professional service LLC's disqualified sole member may wind up its affairs by prosecuting an action for benefits in the company's name.
  • State Farm Mut. Auto. Ins. Co. v Mallela (2005 NY Slip Op 02416) FollowedFraudulently incorporated medical providers are ineligible for no-fault reimbursement under 11 NYCRR 65-3.16 (a) (12).

Cited by

A label shows how the later decision treated this one.

  • Lexington Acupuncture, P.C. v General Assur. Co. (2012 NY Slip Op 22047) FollowedAn insurer may obtain Mallela discovery on sufficient allegations of fraudulent incorporation despite not pleading that defense.
  • Medical Polis, P.C. v Progressive Specialty Ins. Co. (2012 NY Slip Op 50342(U)) FollowedAn insurer may obtain discovery on an unpleaded Mallela defense when sufficient allegations of fraudulent incorporation support the request.
  • A.B. Med. Servs., PLLC v National Grange Mut. Ins. Co. (2012 NY Slip Op 50154(U)) FollowedA provider may wind up its affairs and recover no-fault benefits for services rendered before revocation of its owner's medical license.
  • BR Clinton Chiropractic, P.C. v GEICO Ins. Co. (2020 NY Slip Op 20291)The provider could pursue claims for services rendered before its sole shareholder's chiropractic license was revoked.

Similar decisions

  • Andrew Carothers, M.D., P.C. v GEICO Indem. Co. (2008 NY Slip Op 51756(U))Mallela's good-cause requirement does not apply to a motion for leave to amend an answer to assert fraudulent incorporation.
  • Quality Psychological Servs., P.C. v GEICO Ins. Co. (2010 NY Slip Op 51423(U))An insurer may not amend its answer to assert fraud and unjust-enrichment counterclaims based on a precluded fraudulent-billing defense.
  • Points of Health Acupuncture, P.C. v Lancer Ins. Co. (2010 NY Slip Op 51338(U))The insurer proved EUO nonappearance and timely notices for three claims, but failed to establish tolling for the remaining claims.
  • A.M. Med. Servs., P.C. v Allstate Ins. Co. (2006 NY Slip Op 51426(U))The insurer's conclusory medical-necessity denials were ineffective, but policy-limit exhaustion remained a factual issue.
  • Ocean Diagnostic Imaging, P.C. v Utica Mut. Ins. Co. (2005 NY Slip Op 51747(U))The insurer's untimely EUO request did not toll its denial deadline, and its staged-accident defense lacked admissible proof.
Beynenson Law

Tech-driven New York no-fault collections for healthcare providers.

About the firm

Contact

  • East Hampton, New York

  • 347-746-6001
  • contact@beynensonlaw.com
  • Contact form

Research

  • Search Case Law & Regulations
  • New Decisions
  • Decisions by Court
  • Legal Questions
  • No-Fault Regulations
  • Claim Process & Deadlines
  • Ask No-Fault AI

Arbitration Data

  • Arbitrator Scorecard
  • Award Volume
  • Arbitrator / Carrier Data
  • Provider / Carrier Data
  • Provider / Attorney Data
  • Arbitration Pro Extension

©2026 The Beynenson Law Group, PC. Terms of Use Privacy Policy

Site by khrystev.dev

Attorney Advertising. Prior results do not guarantee a similar outcome. This website provides general information, not legal advice, and using it does not create an attorney-client relationship. Do not send confidential information through this site.